Article provides recommendations for using PD-1 inhibitors with stem cell transplants for treating relapsed Hodgkin lymphoma.
Home / Resource Library / Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evil